Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: A bronchoscopic study
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 133 (4) , 486-491
- https://doi.org/10.1016/s0022-3476(98)70055-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Cystic fibrosis.American Journal of Respiratory and Critical Care Medicine, 1996
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosisPediatric Pulmonology, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Aerosol therapy in the newborn.Archives of Disease in Childhood, 1990
- Dilution of nebulised aerosols by air entrainment in childrenThe Lancet, 1990
- Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilutionJournal of Applied Physiology, 1986
- A simple, rapid, and sensitive DNA assay procedureAnalytical Biochemistry, 1980
- Pulmonary deposition of aerosols in children with cystic fibrosisThe Journal of Pediatrics, 1974